Avacta Group Share Price (AVCT)

45.10 0.00 (0.00%) delayed: 5:44PM GMT
Bid price 44.20 Open price 44.33
Ask price 46.00 Prev close 45.10
High price 45.55 Spread 3.91%
Low price 44.29 Volume 84,088

Register now for FREE live Avacta Group share prices, Avacta Group stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Avacta Group Level 2 Data, indepth research tools and investor commentary for Avacta Group (AVCT) and other London Stock Exchange equities.

Avacta Group Share Price Chart

Advanced Charts >>

Register now for FREE Avacta Group share price charts

Avacta Group Share Price Information

Name Avacta Group Epic AVCT
Sector Pharmaceuticals & Biotechnology ISIN GB00BYYW9G87
Activites Avacta Group plc's (formerly Readybuy plc) principal focus is on its proprietary Affimer technology which is a novel engineered alternative to antibodies that has wide application in Life Sciences for diagnostics, therapeutics and general research and development. Antibodies dominate markets worth in excess of $50bn despite their shortcomings. Affimer technology has been designed to address many of these negative performance issues, principally; the time taken to generate new antibodies, the reliance on an animal's immune response, poor specificity in many cases, and batch to batch variability. Affimer technology is based on a small protein that can be quickly generated to bind with high specificity and affinity to a wide range of protein targets. Avacta has a pre-clinical biotech development programme with an in-house focus on immuno-oncology and bleeding disorders as well as partnered development programmes. Avacta is commercialising non-therapeutic Affimer reagents through licensing to developers of life sciences research tools and diagnostics. Index n/a

Avacta Group Key Numbers

Latest Share Price (p) 45.10 Net Gearing (%) -13.56
Market Capitalisation (£m) 52.24 Gross Gearing (%) 8.70
Shares in issue (m) 115.84 Debt Ratio 0.00
P/E Ratio -3.34 Debt-to-Equity Ratio 0.00
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.10
Dividend Yield (%) 0.00 Price to book value 2.44
Dividend cover (x) 0.00 ROCE (%) -48.53
Earning per share (p) -13.49 EPS Growth (%) -44.90
52 week high / low 63.00 / 21.20 DPS Growth (%) n/a

Avacta Group Director Deals

Dec.Date Type Director Pos No. of Shares
02/01/2019 BUY Tony Gardiner ED 8,196
13/03/2018 BUY Prof Alastair Smith CEO 35,800
21/08/2017 BUY Prof Alastair Smith CEO 33,225
05/07/2017 LOF Michael Albin RES 4,345
21/10/2016 BUY Dr Mike Owen NED 7,763

More Avacta Group Director Deals >>

Avacta Group Company News

12:27 06/02/2019

Avacta (AVCT): A second wake-up call for the market

Hardman & Co Research Hardman & Co Research: Avacta (AVCT): A second wake-up call for the market 06-Feb-2019 / 12:27 GMT/BST Hardman & Co: A second wake-up call for the market Avacta (AVCT) is a pre-clinical stage biotechnology company and the proprietary owner of...

08:32 04/02/2019

ModernaTX takes up option to develop, sell Avacta's affimer technology

Avacta Group said Monday that ModernaTX had exercised its option to enter into an exclusive licensing agreement with respect to certain Affimer molecules that had been generated through collaboration between the two companies. Under the terms of the agreement, Avacta was in line to receive...

07:00 04/02/2019

Moderna Exercises Exclusive Product License Option

RNS Number : 9010O Avacta Group PLC 04 February 2019             4 February 2019   Avacta Group plc   ("Avacta", the "Group" or the "Company")   Moderna Exercises Option for an Exclusive Product License   Avacta Group plc...

More Avacta Group Company News >>

Register now for FREE Avacta Group company news

Avacta Group Share Price Discussions

more than 1 year ago

Avacta Group plc (AVCT)

Avacta Group plc, a UK-based healthcare technology and consumables business, provides innovative and proprietary solutions to the life sciences/healthcare sector through two operating divisions: Avacta Analytical provides high-end analytical instrumentation and services to the...

Register now for FREE Avacta Group share price discussions